SCHEMBL5029802

SCHEMBL5029802

[CH]=CC1CC1C.[CH]=CCCCC

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.31
ALDH1A1 P00352 1/20 0.31
FUCA1 P04066 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7784 0.76
SCHEMBL8742862 0.74 TSHR (0.31) TSHR
Cyclopentane SCHEMBL28067684 0.74 TSHR (0.41) TSHRALDH1A1
SCHEMBL27606771 0.74
Methane SCHEMBL28070762 0.74
Ethyne SCHEMBL28100220 0.74
SCHEMBL272228 0.73
SCHEMBL28098525 0.71 TSHR (0.46) TSHRALDH1A1
SCHEMBL16739294 0.70 ALOX5 (0.38) TSHRALDH1A1FUCA1
SCHEMBL19377 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999167-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR Novolen Technology Holdings, C.V. (NL) 2008-12-10 EP disclosed
WO-2007106348-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) 2007-09-20 WO disclosed
US-20070213204-A1 Ziegler-Natta catalyst with in situ-generated donor NOVOLEN TECHNOLOGY HOLDINGS C.V. 2007-09-13 US disclosed